DOI 10.1080/02656736.2025.2571047
Microwave ablation for T1N1M0 papillary thyroid cancer with lymph node oligometastasis (≤3) - a preliminary study with median follow-up beyond 3 years.
Аннотация
OBJECTIVES
To evaluate the efficacy and safety of microwave ablation (MWA) for T1N1M0 PTC with LN oligometastasis (≤3).
MATERIALS AND
METHODS
In this retrospective study, 41 patients who underwent MWA for T1N1M0 PTC with LN oligometastasis between June 2018 and June 2023 were included. Progression-free survival (PFS), risk factors for tumor progression and complications were assessed.
RESULTS
MWA was successfully performed in all the enrolled patients. The median age was 37 years (IQR: 30.5-46.0), with 13 males and 28 females. After a median follow-up of 43 months (IQR: 37.0-51.5; range: 20-70 months), the 1-, 3-, and 5-year PFS rates were 90.2%, 75.3%, and 62.0%, respectively. The maximum diameter of the PTC was the only significant risk factor for tumor progression (hazard ratio: 7.60; p = 0.010). Major complications included only transient hoarseness, occurring in 7.3% (3/41) of the patients, with full recovery within 2-3 months without treatment.
CONCLUSION
MWA is a feasible treatment option for selected patients with T1N1M0 PTC with LN oligometastasis (≤3), providing favorable therapeutic outcomes and low complication rate.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.